![Marcia Belvin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcia Belvin
Directeur Technique/Scientifique/R&D chez
CYTOMX THERAPEUTICS, INC.
Fortune : 593 737 $ au 31/05/2026
Profil
Marcia P.
Belvin is currently Chief Scientific Officer & Senior Vice President at CytomX Therapeutics, Inc., a position held since 2022.
Education includes an undergraduate degree from Harvard University and a doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 164 927 ( 0,08% ) | 593 737 $ | 31/05/2026 |
Postes actifs de Marcia Belvin
| Sociétés | Poste | Début |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2020 |
Formation de Marcia Belvin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
